Cargando…
Pharmacists’ Role in Managing Patients with Chronic Lymphocytic Leukemia
Chronic lymphocytic leukemia (CLL) is a hematologic malignancy that has seen significant advances in care over the last 5 years with the approval of oral agents such as ibrutinib and venetoclax for the treatment of this disease. As such, there has been a substantial shift away from the traditional c...
Autores principales: | Chen, Kevin Y., Brunk, Kelly M., Patel, Bianka A., Stocker, Kurtis J., Auten, Jessica J., Buhlinger, Kaitlyn M., Muluneh, Benyam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355755/ https://www.ncbi.nlm.nih.gov/pubmed/32230834 http://dx.doi.org/10.3390/pharmacy8020052 |
Ejemplares similares
-
Impact of Oncology Pharmacists on the Knowledge, Attitude, and Practices of Clinicians to Enhance Patient Engagement of Self-Administered Oral Oncolytics
por: Palmer, Shannon, et al.
Publicado: (2021) -
A Pharmacist-Led Oral Chemotherapy Program's Impact on Chronic Myeloid Leukemia Patient Satisfaction, Adherence, and Outcomes
por: Dennison, Taylor, et al.
Publicado: (2021) -
Impact of Adherence to Ibrutinib on Clinical Outcomes in Real-World Patients With Chronic Lymphocytic Leukemia
por: Garner, Lauren M., et al.
Publicado: (2021) -
2018 Hematology/Oncology Pharmacist Association Best Practices for the Management of Oral Oncolytic Therapy: Pharmacy Practice Standard
por: Mackler, Emily, et al.
Publicado: (2019) -
Role of the Advanced Practitioner in the Management of Oral Chemotherapy for Adults With AML
por: Bryant, Ashley Leak, et al.
Publicado: (2022)